0078-0630 : Tobi Podhaler Kit


NDC: 0078-0630
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Tobi Podhaler
Dosage Form: Oral; Respiratory (Inhalation) Capsule
Application #: NDA201688
Rev. Date: 


Appearance:


Markings: NVR;AVCI
Shapes:  Capsule
Colors:  White
Size (mm): 18
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0078-0630-19: 8 CAPSULE IN 1 BOX, UNIT‑DOSE (0078‑0630‑19)
  • 0078-0630-20: 56 CAPSULE IN 1 BOX, UNIT‑DOSE (0078‑0630‑20)
  • 0078-0630-35: 224 PACKAGE IN 1 BOX, UNIT‑DOSE (0078‑0630‑35) > 56 BLISTER PACK IN 1 PACKAGE (0078‑0630‑56) > 4 CAPSULE IN 1 BLISTER PACK (0078‑0630‑11)

Active Ingredients:

  • Tobramycin

Dosage Strength:

  • 28 mg

Inactive Ingredients:

  • 1,2-distearoyl-sn-glycero-3-phosphocholine
  • Calcium Chloride
  • Sulfuric Acid

Pharmaceutical Classes:

  • Aminoglycoside Antibacterial [EPC]
  • Aminoglycosides [CS]

Related Products:

Based on records with the same trade name.
  • 49502-346 Tobi Podhaler 28 mg Oral; Respiratory (Inhalation) Capsule by Mylan Specialty L.p.
  • 49502-401 Tobi Podhaler 28 mg Oral; Respiratory (Inhalation) Capsule by Mylan Specialty L.p.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0630 QR Code

< Prev: 0078-0628Next: 0078-0633 >

Related Discussions:

tobramycin and dexamethasone ophthalmic ointment
ophthalmic ## i would like to know what this ointment is used for? ## This is an antibiotic and steroid that is commonly... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.